Cardinal to buy Har­vard Drug

Los Angeles Times - - BUSINESS BEAT -

Cardinal Health will spend about $1.12 bil­lion to buy phar­ma­ceu­ti­cal dis­trib­u­tor Har­vard Drug Group in a deal that aims to build its generic and over-the-counter drug busi­nesses.

Cardinal said its pur­chase of the pri­vately held com­pany based in Livo­nia, Mich., would pro­vide it with spe­cial­ized pack­ag­ing to help sup­ply hos­pi­tals and other in­sti­tu­tions.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.